Previous Article | Next Article ![]()
Journal of Virology, March 1999, p. 2552-2558, Vol. 73, No. 3
Deutsches Krebsforschungszentrum, Department
of Applied Tumor Virology, Abt. F0100 and Formation INSERM U375,
Heidelberg, Germany
Received 2 October 1998/Accepted 7 December 1998
Minute virus of mice (MVM) shows an oncotropic behavior reflected
by its ability to amplify its genome more efficiently in a number of
transformed versus normal cells. In vivo and in vitro studies revealed
that the major effect of cell transformation on MVM DNA replication
occurs at the level of double-stranded replicative-form amplification.
In particular, resolution of MVM DNA concatemers into monomers was
found to be highly sensitive to neoplastic transformation.
Parvoviruses are small
nuclear-replicating viruses that infect a wide variety of animal
species, including humans (37). Their linear,
single-stranded DNA (ssDNA) genome is characterized by its terminal
hairpins, small size (about 5,000 nucleotides), and low level of
genetic complexity (22). As a result of their limited coding
capacity, parvoviruses rely strongly on cellular factors for their
ongoing life cycle. It is known that the expression of at least some of
these factors is not constitutive but rather is modulated by the
physiological state of the host cell. Parvoviruses multiply exclusively
in proliferating cells, due to the dependence of virus DNA
amplification and expression upon the cell being in S phase
(19). Furthermore, cell permissiveness to parvoviruses is
conditional on an appropriate differentiation state and can be enhanced
by oncogenic transformation (34, 35). This holds true
in particular for the autonomous parvovirus minute virus of mice (MVM).
Transformation of a number of rodent and human cells by ionizing
radiation, chemical carcinogens, tumor viruses, or oncogenes of
cellular or viral origin correlates with an increase in susceptibility
to MVM infection (7, 10, 29, 36). In the systems tested so
far, cell transformation has no significant effect on MVM uptake
(10) but does lead to increased parvoviral genome
replication (2, 10), viral gene transcription (11, 12), infectious virus production (10), and cell
killing (24).
The mechanism underlying the transformation-associated enhancement of
the cell's capacity for amplifying parvoviral DNA is unknown. MVM DNA
replication involves successive steps (22) depicted
schematically in Fig. 1. The
single-stranded virion DNA gets converted into a closed,
double-stranded, monomeric replicative form (cRF) by extension of the
3'-terminal hairpin (left-hand terminus) and ligation of the growing
strand to the folded-back 5' terminus (right-hand terminus) (step 1)
(3, 16). Further processing of cRF DNA requires the activity
of the major viral nonstructural protein NS1. NS1 is involved in the
formation of a strand- and sequence-specific nick at the cRF 5'
telomere, followed by initiation of displacement synthesis and terminal
extension, giving rise to an extended molecule (5'-terminally extended
monomeric replicative form [5'eRF]) (step 2) (3, 15, 46).
Hairpin refolding at the extended terminus, supported by host cell
nuclear factors (3, 13, 14, 47) and efficiently stimulated
by NS1 (47), creates a so-called rabbit-ear structure
(5'-rabbit-eared monomeric replicative form [5'reRF]) (step 3). This
structure provides a primer for strand displacement synthesis and
dimeric replicative-form (dRF) formation (step 4) (3, 5, 19, 46, 47). Subsequent NS1-dependent resolution of concatemer junctions results in the formation of two types of monomeric replicative-form (RF) DNA, with covalently closed (5'eRF) or extended (3'-5'eRF) left-hand termini, respectively (steps 5a and 5b) (17, 18, 20,
21). The 5'eRF molecule generated in this way reenters the cycle
as in step 3, while duplex-to-hairpin transition at the right-hand
palindrome of the 3'-5'eRF molecule (step 6) is thought to lead to the
displacement of single-stranded genomic DNA, which is then immediately
packaged into the preformed empty capsid (22).
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Neoplastic Transformation-Associated Stimulation of
the In Vitro Resolution of Concatemer Junction Fragments from
Minute Virus of Mice DNA

![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References

View larger version (15K):
[in a new window]
FIG. 1.
Modified rolling hairpin model for MVM DNA replication
(according to reference 19). NS1 is depicted as a
small filled circle. Small arrowheads indicate DNA 3' ends. ss, ssDNA;
eRF, extended monomeric RF; v, viral strand; c, complementary strand.
The open polygon in step 6 represents the capsid.
In order to identify MVM DNA replication steps sensitive to host cell transformation, we compared the temporal accumulation of viral DNA replicative intermediates in a pair of normal and transformed cells infected with MVM (prototype strain MVMp) and studied individual replication reactions in an in vitro system (3) using different MVM DNA templates and extracts from normal and transformed cells. A system of choice for studying the effect of transformation on MVMp DNA replication consists of pairs of normal and transformed human fibroblasts (10). Independently of the multiplicity of infection (MOI) used, normal human fibroblasts proved to be quite resistant to the parvovirus, undergoing an abortive infection characterized by a low level of viral DNA replication. In contrast, a number of transformed human fibroblasts show increased permissiveness to the parvovirus. Thus, the human lung fibroblasts MRC-5V1, transformed with simian virus 40 (SV40), sustain a 10-fold-higher level of MVMp DNA replication than MRC-5 cells, their untransformed progenitors (10). In keeping with this observation, production of RF intermediates clearly takes place in infected MRC-5V1 cells, while RF DNA is hardly detectable in normal cells (2, 10).
In order to investigate the differential capacities of MRC-5 and MRC-5V1 cells for supporting MVM DNA amplification, we performed time course analyses of the accumulation of MVM DNA replicative intermediates in this pair of cell lines after infection with MVMp. MRC-5 and MRC-5V1 cultures (2.5 × 105 cells) were seeded in 35-mm-diameter petri dishes and inoculated with MVMp at an MOI of 5 PFU per cell. At various times postinfection (p.i.), intracellular parvoviral DNA was extracted by using the Hirt procedure, including proteinase K digestion (27). DNA replicative intermediates were size fractionated via 0.8% agarose gel electrophoresis, blotted, and hybridized with an MVM-specific 32P-labeled DNA probe synthesized from a SalI-digested MVM DNA clone, p98 (1). ssDNA isolated from MVM virions by sodium dodecyl sulfate-proteinase K treatment and phenol extraction (45) was used as a size marker (Fig. 2A, lane 1). The marker DNA minor band corresponding to monomeric RF (mRF) can be assigned to the spontaneous reannealing of the small fraction of packaged plus strands with the major virion DNA species (which are of minus polarity) (4). Viral DNA extracted 2 h p.i. was mostly present in the unreplicated single-stranded form (Fig. 2A, lanes 2 and 6). The difference in the amounts of input ssDNA associated with MRC-5 and MRC-5V1 cells at this early time reflects experimental fluctuations, as indicated by the data from a series of experiments. This is in keeping with the similar competence of both cell types for MVMp uptake as reported earlier (10). Double-stranded RF DNA was also detected in minute amounts 2 h p.i. and is thought to arise from plus and minus input viral DNA strand reannealing, as mentioned above. The amplification of MVM DNA in infected cells, as measured by Southern blotting (Fig. 2A, lanes 2 to 9), was quantitated by densitometric scanning. RF values are plotted as a function of time p.i. in Fig. 2B after subtraction of the mRF background signal detected 2 h p.i. MRC-5 and MRC-5V1 cells could be distinguished by their differing capacities for replicating MVM DNA over the course of time. MRC-5 cells sustained the formation of a limited but significant amount of monomeric RF species up to 18 h p.i. but subsequently failed to further amplify this DNA (Fig. 2A, lanes 3 to 5, and Fig. 2B). In contrast, mRF formation in MRC-5V1 cells was followed by the amplification of this species, as revealed by the time-dependent increase in the corresponding signal (Fig. 2A, lanes 7 to 9, and Fig. 2B). In agreement with the involvement of multimeric DNA species in RF replication (19), mRF amplification in transformed MRC-5V1 cells was accompanied by the clear-cut appearance of dRF molecules (Fig. 2A, lanes 8 and 9) at a position at which a band was hardly detectable in extracts from infected normal cells (Fig. 2A, lanes 4 and 5). Given the overlap between the conversion of input ssDNA into mRF and the amplification of mRF in infected asynchronous cells, these experiments do not allow the assessment of a possible quantitative effect of cell transformation on the conversion step. However, the data clearly point to a qualitative difference between normal and transformed cells at the level of double-stranded RF DNA amplification. The additional band detected in both MRC-5 and MRC-5V1 cells, designated X (Fig. 2A), has been previously identified by others (43) as an RNA-DNA duplex whose biological significance remains unclear. MVM DNA replication has been reported to depend on the S phase of the cell cycle (19). Since MRC-5 and MRC-5V1 cells do not grow at the same rate, a difference in their distribution through the mitotic cycle may conceivably contribute to the observed variation in replication efficiency. To test this possibility, we conducted fluorescence-activated cell sorter analyses with exponentially growing MRC-5 and MRC-5V1 cells. These studies revealed that both cultures contained approximately the same fraction (25 to 30%) of S-phase cells (data not shown). This argues against accumulation in S phase being responsible for the greater capacity of MRC-5V1 cultures for MVM DNA amplification.
|
In order to understand the molecular mechanisms underlying the increased amplification of mRF DNA in transformed fibroblasts, MRC-5 and MRC-5V1 cells were then compared for their ability to support the individual steps of MVM DNA replication by an in vitro assay. DNA replication reactions were carried out as previously reported (3) with cytosolic extracts (10 to 100 µg of proteins) from MRC-5 and MRC-5V1 cells. About 200 ng of purified baculovirus-produced NS1 (32) was added where required. The reaction was started by addition of natural or cloned viral DNA template (20 or 100 ng, respectively) and performed for 1 h at 37°C. After the reaction was stopped, replication products were purified as described elsewhere (3) and analyzed either directly or after restriction digestion by 0.8% agarose or 5% polyacrylamide gel electrophoresis, as indicated. Natural MVM mRF DNA templates, i.e., cRF and 5'eRF (Fig. 1), were obtained from MVM-infected A9 cells by Hirt extraction, centrifugation through 5 to 30% neutral sucrose gradients, and further purification on 10 to 30% alkaline sucrose gradients (3, 39).
We have previously shown that the MVM RF DNA intermediate that is covalently closed at both termini (cRF DNA) is processed in vitro in a reaction involving NS1-specific nicking of the right (genomic 5') telomere, followed by initiation of displacement synthesis, copying of the right-end hairpin sequence, and formation of a terminally extended molecule (5'eRF) (3, 46) (Fig. 1, step 2). Using an MVM DNA preparation containing predominantly cRF DNA as a source of template, we tested the ability of MRC-5 and MRC-5V1 cell extracts to sustain resolution of the right-end telomere into an extended open structure in the presence of NS1. For the analysis of short terminal fragments, replication products were digested with PshAI and fractionated by native 5% polyacrylamide gel electrophoresis. PshAI cleaves MVM DNA at nucleotide 4916, giving rise to right-end fragments of 130 or 254 bp, respectively, depending on whether the telomere is in the hairpin or extended configuration (3, 46). While the hairpin fragment is only weakly labeled due to nonspecific repair synthesis, the extended species becomes heavily labeled as the result of the nicking and extension reactions leading to the copying of the terminal hairpin sequence. As illustrated in Fig. 3A (lanes 1 and 5), similar competences for sustaining the NS1-induced extension reaction were observed in the presence of small amounts of extract from either MRC-5 or MRC-5V1 cells. By increasing the concentration of MRC-5V1 cell extract, the efficiency of right-end resolution could be further enhanced (Fig. 3A, lanes 6 to 8), whereas the same increase in the amount of MRC-5 cell extract had no significant effect (Fig. 3A, lanes 2 to 4). This suggests that transformation is associated with the production or activation of a cellular factor(s) that stimulates nicking and/or extension of the 5'-terminal hairpin. As a consequence, MRC-5 cells showed a relative, but not absolute, impairment in this reaction, which may contribute to the lack of MVM DNA amplification found in normal cells under in vivo conditions but appears insufficient to account for this defect alone.
|
The 5'eRF product resulting from the right-end resolution of cRF can be further processed in vitro, leading to the formation of dRF DNA in an NS1-stimulated reaction (3) (Fig. 1, steps 3 and 4). To compare normal and transformed cells for their ability to initiate replication on 5'-terminally extended DNA, in vitro replication reactions were conducted in the presence of NS1 by using 5'eRF template DNA purified from MVM-infected mouse fibroblasts. Figure 3B shows the analysis of the undigested replication products by 0.8% agarose gel electrophoresis. When incubated with extracts from human fibroblasts, the 5'eRF monomer template (mRF band) was specifically labeled, presumably as a result of re-nicking and extension events taking place at the RF right end (3, 5, 46). In addition, the formation of a distinct DNA species was observed at a position corresponding to an apparent molecular size of about 10 kbp. The identity of this species with MVM dRF DNA has been demonstrated in previous experiments (3). As is apparent from Fig. 3B, extracts from both normal and transformed fibroblasts were able to drive the formation of dRF molecules from 5'eRF DNA in the presence of NS1. Extracts from the transformants were two- to threefold more efficient in this respect than extracts from normal cells. However, as this impairment is only moderate under in vitro conditions, limitations to RF multimerization may contribute to, but cannot alone account for, the lack of viral DNA amplification in the normal cells.
Most dimer duplex intermediates formed in MVM-infected cells contain monomeric subunits connected in a left-to-left-end (viral 3'-to-3'-end) manner, while a small minority (about 5%) contain a right-to-right-end (viral 5'-to-5'-end) junction (22). These palindromic junction regions of MVM dRF are resolved to generate monomeric forms in the presence of NS1 both in vivo and in vitro (17, 18, 20, 21, 28). The MVM terminal palindromes are not perfectly symmetrical; each consists of two arms with slightly different sequences designated A and B (18). Resolution of the 3'-to-3' junction is asymmetrical and involves an initial nick in the B arm, giving rise to resolved A and B arms that predominantly terminate in the extended or turnaround configuration, respectively (18, 21). In contrast, 5'-to-5' junction fragments are resolved symmetrically and give rise to predominantly extended-form structures from both arms of the palindrome (17). We examined the resolution of MVM DNA concatemeric junctions (Fig. 1, step 5) in extracts from MRC-5 and MRC-5V1 cells. As templates, we used the pUC18-based plasmid pLEB711, containing the palindromic 711-bp PstI fragment derived from the left-to-left-end junction of dRF DNA (20), and the pUC19-based plasmid pREB1412, spanning the right-to-right-end bridge (20). Resolution reactions were carried out for 1 h in the presence of cytosolic extracts. Reaction products were digested with ScaI, which cuts once within the vector sequence and generates two fragments of differing sizes from resolved molecules. Digestion products were fractionated by 0.8% agarose gel electrophoresis.
As shown in Fig. 4A (lanes 1 to 4), bands corresponding to the linearized forms of unresolved pLEB711 and pREB1412 plasmids were obtained, migrating at the anticipated 3,430- and 4,340-bp positions, respectively. From the results of immunoprecipitation reactions, Cotmore et al. (17, 18) concluded that these forms consist in part of NS1-bound superstructures arising from incomplete resolution (i.e., NS1-mediated nicking and initiation of rolling-circle replication) and in part of unresolved NS1-free molecules probably labeled by repair synthesis. This is in line with control reactions carried out in the absence of NS1 in the present study (data not shown). In the presence of NS1, linear forms of pLEB711 became labeled to similar extents in extracts from MRC-5V1 and MRC-5 cells (Fig. 4, lanes 1 and 2). In contrast, the labeling of linearized pREB1412 was much lower in extracts from MRC-5 than in extracts from MRC-5V1 cells (Fig. 4, lanes 3 and 4). We interpret this result in favor of the involvement of transformation-dependent cellular factors in NS1-induced resolution of the right-to-right-end junction, as supported by the analysis of the junction resolution products shown below. The band migrating between the 3'-to-3' linear form and the 3'-to-3' B replication product (Fig. 4A, lanes 1 and 2) results from nonspecific labeling of the pUC18 vector DNA.
|
Specific resolution products corresponding to the A and B arms of the palindromes were detected for both pLEB711 and pREB1412 clones when reactions were performed with extracts from MRC-5V1 cells (Fig. 4A, lanes 1 and 3). Doublet bands were visible at the positions of the A and B arms of resolved pREB1412 (Fig. 4, lane 3), in agreement with the above-mentioned occurrence of each arm in both turnaround and extended configurations. In contrast, no resolved fragments could be detected when reactions were performed in the presence of MRC-5 cell extracts (Fig. 4A, lanes 2 and 4).
To ascertain that the failure of MRC-5 cell extracts to support concatemer resolution was specific for this reaction, we reexamined the capacity of the same MRC-5 extracts for supporting the nicking and extension reaction described above for cRF. DNA products from replication reactions carried out in the presence of cRF template and either MRC-5V1 or MRC-5 cell extracts were digested with PshAI and electrophoresed through a 5% polyacrylamide gel. As illustrated in Fig. 4B (lanes 5 and 6), this analysis confirmed the ability of both extracts to support nicking and extension of the cRF right-hand telomere. In contrast, resolution of 3'-to-3' or 5'-to-5' concatemeric junctions was supported only by extracts from transformed cells, as revealed by the analysis of PstI- and XbaI-digested resolution products in the same gel (Fig. 4B, lanes 1 to 4). This comparison suggests that the concatemer resolution reaction plays a key role in restricting the efficiency of parvovirus DNA replication in normal human fibroblasts.
In order to gain information as to whether the differential capacity of MRC-5 and MRC-5V1 cells for supporting concatemer resolution was due to an activator(s) present in transformed cells or an inhibitor(s) present in normal cells, we performed in vitro replication reactions in the presence of various combinations of cell extracts. As shown in Fig. 5 (lanes 2 to 5), the efficiency of the 3'-to-3' junction resolution in MRC-5V1 cell extracts was not affected by the addition of increasing amounts of MRC-5 cell extracts. In contrast, increasing the amount of MRC-5V1 cell proteins led to a dose-dependent stimulation of the resolution reaction in the absence (Fig. 5, lanes 6 to 9) or presence (data not shown) of MRC-5 cell extracts. These results argue for the presence of a factor(s) able to activate 3'-to-3' concatemer resolution in transformed cells and against the presence of a resolution inhibitor in normal cells.
|
MVM DNA replication is known to depend upon the entry of host cells into S phase. As mentioned above, MRC-5 and MRC-5V1 cultures comprise similar fractions of S-phase cells; hence, the distinctive capacity of the latter for in vitro concatemer resolution cannot be assigned to their enrichment in S-phase cells. Furthermore, extracts prepared from MRC-5 cells that were highly (99%) synchronized in S phase still proved to be unable to resolve concatemeric junctions in vitro (data not shown), again arguing against a major contribution of cell cycle-related variations to the differential capacity of normal and transformed cells for sustaining this reaction. It should also be stated that MRC-5V1 cells are transformed by SV40 and express the viral large T antigen (40) (data not shown) which is essential for the initiation of SV40 DNA replication (38) and might therefore potentially facilitate the resolution of MVM DNA concatemers. However, the human fibroblast cell line KMST-6, which was transformed by gamma-irradiation, was found to efficiently amplify MVM DNA (10), and extracts from these cells proved to be as active as extracts from MRC-5V1 cells in sustaining the 3'-to-3' junction resolution in the present assay (data not shown). This shows that the stimulation of MVM DNA amplification is not restricted to cells expressing the SV40 large T antigen, arguing for the involvement of transformation-dependent cellular factors in this modulation.
In this study, we provide evidence that the transformation dependency of MVM DNA amplification results from the stimulated replication of double-stranded intermediates. In particular, the resolution of MVM DNA concatemer junctions is strongly enhanced in transformed versus normal cells. This holds true for the resolution of both 3'-to-3' and 5'-to-5' junctions. Interestingly, normal cells appeared to be deficient in the first stage of 5'-to-5' resolution, presumably including NS1-mediated nicking and initiation of strand displacement synthesis (17, 18). In contrast, MRC-5 cells were competent for this initial stage of the 3'-to-3' resolution, although they were unable to complete the process. This indicates that the 3'-to-3' and 5'-to-5' junctions differ, at least in part, in their requirements for cellular resolution factors and that the full resolution of both types of junctions is subject to a transformation-sensitive restriction. Furthermore, our data suggest that the failure of normal cells to support dRF internal resolution can be traced back to the absence of a transformation-specific activator(s). Given the failure of dimer resolution in extracts from untransformed cells, one would predict an accumulation of dRF intermediates in MVM-infected MRC-5 cells. This cannot be assessed from Fig. 2, due to the low RF yields achieved with these cells. However, quantitation of the RF signals present on the original autoradiograph showed that the dRF/mRF ratio was indeed markedly higher for infected MRC-5 cells than for MRC-5V1 cells. This is in keeping with the hypothesis that MVM DNA replication becomes blocked at the concatemeric resolution stage during infection of normal MRC-5 cells. It is worth noting that the original host cells for MVM replication are of mouse origin, while human fibroblasts were used in the present study. Therefore, the possibility that at least a partly different limitation(s) to MVM DNA amplification takes place in the mouse system needs to be considered, although no qualitative difference could be observed so far between mouse and human cell extracts in their capacity for MVM DNA replication in vitro (3, 18). Furthermore, transformation of mouse fibroblasts, as induced in particular by SV40, was also shown to correlate with an increase in their ability to amplify MVM DNA (10).
Little is known about the cellular factors required for MVM DNA
replication. DNA polymerase delta (pol-
) appears to be involved (8, 13), implying that the auxiliary factors replication protein A (RPA), replication factor C, and proliferating cell nuclear
antigen (PCNA) are also likely to take part in parvovirus DNA
replication. RPA and PCNA have indeed been shown to participate in the
in vitro resolution of both 3'-to-3' and 5'-to-5' concatemers (8). In the case of 3'-to-3' concatemer resolution, a host cell component designated parvovirus initiation factor (8, 9) was shown to activate the endonuclease function of NS1 by binding to a consensus motif specific for the activated
transcription factor (8, 9, 28). Furthermore, MVM
replication factors were found to bind to cis-regulatory
elements located inboard of the MVM 5' palindrome (5, 42),
and interaction of the MVM 5' hairpin with members of the
high-mobility-group (HMG) proteins has recently been reported
(23). HMG protein was actually shown to be the only cellular
protein required to allow the viral initiator protein NS1 to nick the
right-hand (5') MVM hairpin in a sequence-specific fashion.
Neoplastic transformation is characterized by deregulation of cell
growth and division, two complex processes that are controlled by
multiple factors in normal cells (32). Certain cell
regulatory pathways have been shown to be particularly altered in a
majority of cancers (32), in association with changes in the
levels of various cellular proteins, including DNA replication factors. The level of PCNA was found to be 10-fold higher in MRC-5V1 cells than
in MRC-5 cells (data not shown) (6, 25). Conversely, we
detected higher quantities of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 (26) in MRC-5 cells than in MRC-5V1
cells (data not shown). p21WAF1/CIP1 has been shown to
interact specifically with PCNA, leading to a block in
pol-
-dependent DNA synthesis (31, 40, 44). Furthermore, quaternary complexes between p21WAF1/CIP1, cyclins,
cyclin-dependent kinases, and PCNA are disrupted in transformed cells
(30, 49), resulting in the release of
p21WAF1/CIP1-free PCNA that is able to activate pol-
.
Thus, the increase in PCNA levels and the decrease in
p21WAF1/CIP1 levels, both of which are associated with the
MRC-5 cell's transformation, deserve to be considered as possible
contributors to the overall enhancement of MVM DNA amplification.
However, the observed quantitative differences in these factors are
unlikely by themselves to account for the inability of MRC-5 cell
extracts to support detectable resolution of MVM DNA concatemers. This
leads us to postulate the involvement of a transformation-specific
factor(s), the nature of which remains to be established, in the
resolution of MVM concatemeric intermediates. The above-mentioned HMG
protein, which participates in the resolution of the MVM DNA right end
(23), is known to be differentially expressed as a function
of neoplastic transformation (48). This raises the
intriguing possibility that the difference observed between MRC-5 and
MRC-5V1 cells in efficiency in resolving cRF right-hand and
tail-to-tail concatemers may be traced back to their different HMG
protein contents.
| |
ACKNOWLEDGMENTS |
|---|
We thank Jan Cornelis for helpful discussions. We are grateful to Laurent Deleu for performing fluorescence-activated cell sorter analyses and to Claudia Plotzky for technical assistance with cell culture. We are indebted to Jason King for help in preparation of the manuscript. We thank Susan Cotmore and Peter Tattersall, Yale University School of Medicine, New Haven, Conn., for kindly providing the pLEB711 and pREB1412 plasmids and for critical reading of the manuscript.
G.K.-S. was supported by a grant from the Alexander von Humboldt Foundation.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Deutsches Krebsforschungszentrum, Applied Tumor Virology, Abt. F0100 and Formation INSERM U375, Postfach 101949, D-69009 Heidelberg, Germany. Phone: (49) 6221 42 49 60. Fax: (49) 6221 42 49 62. E-mail: j.rommelaere{at}dkfz-heidelberg.de.
Present address: CNEVA-Ploufragan, Unité de Virologie
Immunologie Parasitologie Aviaires et Cunicoles, BP 53, F-22440
Ploufragan, France.
Present address: Department of Internal Medicine, University of
Heidelberg, D-69115 Heidelberg, Germany.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Antonietti, J. P.,
R. Sahli,
P. Beard, and B. Hirt.
1988.
Characterization of the cell type-specific determinant in the genome of minute virus of mice.
J. Virol.
62:552-557 |
| 2. | Avalosse, B., Y. Q. Chen, J. J. Cornelis, N. Duponchel, P. Becquart, M. Namba, and J. Rommelaere. 1987. Amplification of parvoviral DNA as a function of host-cell transformation, p. 140-152. In H. Zur Hausen, and J. R. Schlehofer (ed.), The role of DNA amplification in carcinogenesis. J. P. Lippincott Company, Philadelphia, Pa. |
| 3. | Baldauf, A. Q., K. Willwand, E. Mumtsidu, J. P. F. Nüesch, and J. Rommelaere. 1997. Specific initiation of replication at the right-end telomere of the closed species of minute virus of mice replicative-form DNA. J. Virol. 71:971-980[Abstract]. |
| 4. | Berns, K. I. 1996. Parvoviridae: the viruses and their replication, p. 2173-2197. In B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.), Virology. Lippincott-Raven Publishers, Philadelphia, Pa. |
| 5. | Brunstein, J., and C. R. Astell. 1997. Analysis of the internal replication sequence indicates that three elements are required for efficient replication of minute virus of mice minigenomes. J. Virol. 71:9087-9095[Abstract]. |
| 6. | Celis, J. E., K. Dejgaard, P. Madsen, H. Leffers, B. Gesser, B. Honore, et al. 1990. The MRC-5 human embryonal lung fibroblast two-dimensional gel cellular protein database: quantitative identification of polypeptides whose relative abundance differs between quiescent, proliferating and SV-40 transformed cells. Electrophoresis 11:1072-1113[Medline]. |
| 7. |
Chen, Y. Q.,
F. de Foresta,
J. Hertoghs,
B. L. Avalosse,
J. J. Cornelis, and J. Rommelaere.
1986.
Selective killing of simian virus 40-transformed human fibroblasts by parvovirus H-1.
Cancer Res.
46:3574-3579 |
| 8. | Christensen, J., S. F. Cotmore, and P. Tattersall. 1997. A novel cellular site-specific DNA-binding protein cooperates with the viral NS1 polypeptide to initiate parvovirus DNA replication. J. Virol. 71:1405-1416[Abstract]. |
| 9. | Christensen, J., S. F. Cotmore, and P. Tattersall. 1997. Parvovirus initiation factor PIF: a novel human DNA-binding factor which coordinately recognizes two ACGT motifs. J. Virol. 71:5733-5741[Abstract]. |
| 10. |
Cornelis, J. J.,
P. Becquart,
N. Duponchel,
N. Salomé,
B. L. Avalosse,
M. Namba, and J. Rommelaere.
1988.
Transformation of human fibroblasts by ionizing radiation, a chemical carcinogen, or simian virus 40 correlates with an increase in susceptibility to the autonomous parvoviruses H-1 virus and minute virus of mice.
J. Virol.
62:1679-1686 |
| 11. |
Cornelis, J. J.,
N. Spruyt,
P. Spegelaere,
E. Guetta,
S. F. Darawshi,
S. F. Cotmore,
J. Tal, and J. Rommelaere.
1988.
Sensitization of transformed rat fibroblasts to killing by parvovirus minute virus of mice correlates with an increase in viral gene expression.
J. Virol.
62:3438-3444 |
| 12. |
Cornelis, J. J.,
Y. Q. Chen,
N. Spruyt,
N. Duponchel,
S. F. Cotmore,
P. Tattersall, and J. Rommelaere.
1990.
Susceptibility of human cells to killing by the parvoviruses H-1 and minute virus of mice correlates with viral transcription.
J. Virol.
64:2537-2544 |
| 13. | Cossons, N., E. A. Faust, and M. Zannis-Hadjopoulos. 1996. DNA polymerase delta-dependent formation of a hairpin structure at the 5' terminal palindrome of the minute virus of mice. Virology 216:258-264[Medline]. |
| 14. | Cossons, N., M. Zannis-Hadjopoulos, P. Tam, C. R. Astell, and E. A. Faust. 1996. The effect of regulatory sequence elements upon the initiation of DNA replication of the minute virus of mice. Virology 224:320-325[Medline]. |
| 15. |
Cotmore, S. F., and P. Tattersall.
1988.
The NS-1 polypeptide of minute virus of mice is covalently attached to the 5' termini of duplex replicative-form DNA and progeny single strands.
J. Virol.
62:851-860 |
| 16. |
Cotmore, S. F.,
M. Gunther, and P. Tattersall.
1989.
Evidence for a ligation step in the DNA replication of the autonomous parvovirus minute virus of mice.
J. Virol.
63:1002-1006 |
| 17. | Cotmore, S. F., J. P. F. Nüesch, and P. Tattersall. 1992. In vitro excision and replication of 5' telomeres of minute virus of mice DNA from cloned palindromic concatemer junctions. Virology 190:365-377[Medline]. |
| 18. |
Cotmore, S. F.,
J. P. F. Nüesch, and P. Tattersall.
1993.
Asymmetric resolution of a parvovirus palindrome in vitro.
J. Virol.
67:1579-1589 |
| 19. | Cotmore, S. F., and P. Tattersall. 1987. The autonomously replicating parvoviruses of vertebrates. Adv. Virus Res. 33:91-169[Medline]. |
| 20. |
Cotmore, S. F., and P. Tattersall.
1992.
In vivo resolution of circular plasmids containing concatemer junction fragments from minute virus of mice DNA and their subsequent replication as linear molecules.
J. Virol.
66:420-431 |
| 21. | Cotmore, S. F., and P. Tattersall. 1994. An asymmetric nucleotide in the parvoviral 3' hairpin directs segregation of a single active origin of DNA replication. EMBO J. 13:4145-4152[Medline]. |
| 22. | Cotmore, S. F., and P. Tattersall. 1995. DNA replication in the autonomous parvoviruses. Semin. Virol. 6:271-281. |
| 23. |
Cotmore, S. F., and P. Tattersall.
1998.
High-mobility group 1/2 proteins are essential for initiating rolling-circle-type DNA replication at a parvovirus hairpin origin.
J. Virol.
72:8477-8484 |
| 24. |
Guetta, E.,
M. Mincberg,
S. Mousset,
C. Bertinchamps,
J. Rommelaere, and J. Tal.
1990.
Selective killing of transformed rat cells by minute virus of mice does not require infectious virus production.
J. Virol.
64:458-462 |
| 25. | Hall, P. A., P. J. Coates, R. A. Godlab, I. R. Hart, and D. P. Lane. 1994. Proliferating cell nuclear antigen expression in non-cycling cells may be induced by growth factors in vivo. Br. J. Cancer 70:244-247[Medline]. |
| 26. | Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816[Medline]. |
| 27. | Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369[Medline]. |
| 28. | Liu, Q., and C. R. Astell. 1996. A murine host cell factor required for nicking of the dimer bridge of MVM recognizes two CG nucleotides displaced by 10 base pairs. Virology 224:105-113[Medline]. |
| 29. | Mousset, S., J. Cornelis, N. Spruyt, and J. Rommelaere. 1986. Transformation of established murine fibroblasts with an activated cellular Harvey-ras oncogene or the polyoma virus middle T gene increases cell permissiveness to parvovirus minute virus of mice. Biochimie 68:951-955[Medline]. |
| 30. |
Peterson, S. R.,
D. M. Gadbois,
E. M. Bradbury, and P. M. Kraemer.
1995.
Immortalization of human fibroblasts by SV40 large T antigen results in the reduction of cyclin D1 expression and subunit association with proliferating cell nuclear antigen and Waf1.
Cancer Res.
55:4651-4657 |
| 31. | Podust, V. N., L. M. Podust, F. Goubin, B. Ducommun, and U. Hübscher. 1995. Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21. Biochemistry 34:8869-8875[Medline]. |
| 32. | Rao, R. N. 1996. Targets for cancer therapy in the cell cycle pathway. Curr. Opin. Oncol. 8:516-524[Medline]. |
| 33. | Riley, L. K., R. Knowles, N. Purdy, N. Salomé, D. Pintel, R. R. Hook, Jr., C. L. Franklin, and C. L. Besch-Williford. 1996. Expression of recombinant parvovirus NS1 protein by a baculovirus and application to serologic testing of rodents. J. Clin. Microbiol. 34:440-446[Abstract]. |
| 34. | Rommelaere, J. 1990. Action anticancéreuse des parvovirus. Médecine/Sciences 6:534-543. |
| 35. | Rommelaere, J., and J. J. Cornelis. 1991. Antineoplastic activity of parvoviruses. J. Virol. Methods 33:233-251[Medline]. |
| 36. | Salomé, N., B. van Hille, N. Duponchel, G. Meneguzzi, F. Cuzin, J. Rommelaere, and J. J. Cornelis. 1990. Sensitization of transformed rat cells to parvovirus MVMp is restricted to specific oncogenes. Oncogene 5:123-130[Medline]. |
| 37. | Siegl, G. 1984. Biology and pathogenicity of autonomous parvoviruses, p. 297-362. In K. I. Berns (ed.), The parvoviruses. Plenum Press, New York, N.Y. |
| 38. | Stahl, H., P. Droge, and R. Knippers. 1986. DNA helicase activity of SV40 large tumor antigen. EMBO J. 5:1939-1944[Medline]. |
| 39. |
Straus, S. E.,
E. D. Sebring, and J. A. Rose.
1976.
Concatemers of alternating plus and minus strands are intermediates in adenovirus-associated virus synthesis.
Proc. Natl. Acad. Sci. USA
73:742-746 |
| 40. |
Su, Z. Z.,
L. P. Guo,
F. Dupont,
B. Avalosse, and J. Rommelaere.
1988.
Positive selection of human cells lacking several transformation parameters from an SV40-transformed culture by means of parvovirus H-1.
Carcinogenesis
9:1395-1400 |
| 41. |
Szepsi, A.,
E. W. Gelfand, and J. J. Lucas.
1994.
Association of proliferating cell nuclear antigen with cyclin-dependent kinases and cyclins in normal and transformed human T lymphocytes.
Blood
84:3413-3421 |
| 42. |
Tam, P., and C. R. Astell.
1994.
Multiple cellular factors bind to cis-regulatory elements found inboard of the 5' palindrome of minute virus of mice.
J. Virol.
68:2840-2848 |
| 43. |
Tullis, G.,
R. V. Schoborg, and D. Pintel.
1994.
Characterization of the temporal accumulation of minute virus of mice replicative intermediates.
J. Gen. Virol.
75:1633-1646 |
| 44. | Waga, S., G. J. Hannon, D. Beach, and B. Stillman. 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574-578[Medline]. |
| 45. | Willwand, K., and O. R. Kaaden. 1988. Capsid protein VP1 (p85) of Aleutian disease virus is a major DNA-binding protein. Virology 166:52-57[Medline]. |
| 46. | Willwand, K., A. Q. Baldauf, L. Deleu, E. Mumtsidu, E. Costello, P. Beard, and J. Rommelaere. 1997. The minute virus of mice (MVM) nonstructural protein NS1 induces nicking of MVM DNA at a unique site of the right-end telomere in both hairpin and duplex conformations in vitro. J. Gen. Virol. 78:2647-2655[Abstract]. |
| 47. |
Willwand, K.,
E. Mumtsidu,
G. Kuntz-Simon, and J. Rommelaere.
1998.
Initiation of DNA replication at palindromic telomeres is mediated by a duplex-to-hairpin transition induced by the minute virus of mice nonstructural protein NS1.
J. Biol. Chem.
273:1165-1174 |
| 48. | Wunderlich, V., and M. Bottger. 1997. High-mobility-group proteins and cancer-an emerging link. J. Cancer Res. Clin. Oncol. 123:133-140[Medline]. |
| 49. |
Xiong, Y.,
H. Zhang, and D. Beach.
1993.
Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation.
Genes Dev.
7:1572-1583 |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»